Can progesterone supplementation increase total cholesterol and LDL‑cholesterol levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Progesterone Supplementation and Cholesterol Levels

The effect of progesterone supplementation on cholesterol depends critically on the type of progestin used: newer-generation progestins (desogestrel, norgestimate, gestodene) and micronized progesterone tend to lower LDL-cholesterol and raise HDL-cholesterol, while androgenic progestins (norgestrel, levonorgestrel) and medroxyprogesterone acetate (MPA) increase LDL-cholesterol and decrease HDL-cholesterol. 1

Type-Specific Lipid Effects

Newer-Generation Progestins (Favorable Profile)

  • Latest-generation progestins (desogestrel, norgestimate, gestodene) raise HDL-cholesterol and lower LDL-cholesterol levels. 1
  • A meta-analysis of 18 studies showed contraceptives containing desogestrel increased HDL-cholesterol by 0.058 g/L and reduced LDL-cholesterol by 0.045 g/L. 1

Micronized Progesterone (Neutral to Favorable)

  • Micronized progesterone has no adverse impact on total cholesterol, LDL, HDL, or triglycerides. 2
  • The American College of Endocrinology and American Association of Clinical Endocrinologists note that differences in lipid effects exist among various progestational compounds. 3
  • Lipid profiles should be monitored to determine individual cardiovascular risk when using any progestin. 3

Androgenic Progestins (Unfavorable Profile)

  • Progestins with androgenic activity (norgestrel, levonorgestrel) typically increase LDL-cholesterol and decrease HDL-cholesterol levels. 1
  • Medroxyprogesterone acetate (MPA) also increases LDL-cholesterol and decreases HDL-cholesterol. 1
  • MPA worsens lipid profiles compared with alternative progestins, especially when combined with estrogen, attenuating the HDL-raising effect of estrogen therapy. 4
  • A 2024 meta-analysis of 35 randomized controlled trials showed MPA significantly decreased HDL-cholesterol (WMD: -3.34 mg/dL) and had a non-significant increase in LDL-cholesterol. 5

Clinical Context: Estrogen-Progestin Combinations

  • The overall impact on lipid parameters is modest and depends on the pharmacological properties of the specific progestin used. 1
  • When estrogen is combined with low-dose norethisterone, the dominant estrogen effect reduces LDL-cholesterol and increases HDL-cholesterol. 1
  • The estrogen component is primarily responsible for increasing triglycerides and HDL-cholesterol while decreasing LDL-cholesterol. 1

Monitoring and Safety Thresholds

  • Lipid profiling should be performed 3 to 6 months after starting any hormonal contraception or hormone replacement therapy. 1
  • LDL-cholesterol levels above 2.20 g/L (220 mg/dL) in women with no cardiovascular risk factors contraindicate estrogen-progestin contraception but allow progestin-only contraception, preferably using compounds without significant androgenic activity. 1
  • For women with cardiovascular risk factors, the tolerated LDL-cholesterol threshold should be lowered by 0.30 g/L for each additional risk factor. 1
  • Triglyceride levels exceeding 2.00 g/L (200 mg/dL) contraindicate estrogen-progestin contraception; progestin-based contraception should be used instead. 1

Practical Algorithm for Progestin Selection

When endometrial protection is needed in women receiving estrogen:

  • First-line choice: Micronized progesterone (100 mg daily continuous or 200 mg daily for 12-14 days/month) due to neutral lipid effects and superior cardiovascular safety profile. 2
  • Second-line: Newer-generation progestins (desogestrel, norgestimate, gestodene) if micronized progesterone is unavailable or not tolerated. 1
  • Avoid: Androgenic progestins and MPA in women with dyslipidemia, cardiovascular risk factors, or established cardiovascular disease due to unfavorable lipid effects. 4, 5

Common Pitfall

Do not assume all progestins have identical metabolic effects. The specific type of progestin determines whether cholesterol levels improve, remain neutral, or worsen. 1, 3, 1 When hypercholesterolemia occurs during estrogen-progestin therapy, verify this is not an isolated HDL-cholesterol increase (common with ethinyl estradiol), which does not require treatment modification. 1

References

2
Guideline

Micronized Progesterone: Evidence‑Based Indications and Clinical Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3
Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

4
Guideline

Cardiovascular, Metabolic, and Thrombotic Risks of Oral Medroxyprogesterone Acetate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Does high-dose intramuscular progesterone for IVF luteal support increase LDL cholesterol or hinder weight loss?
Can progesterone increase low‑density lipoprotein (LDL) cholesterol and total cholesterol and make weight loss difficult?
What are the 2026 cholesterol management guidelines, including recommended screening age, risk assessment tools, LDL‑C target levels, and treatment recommendations such as statin intensity, ezetimibe, PCSK9 inhibitors, coronary calcium scoring, and management of elevated triglycerides and lipoprotein(a)?
In a 32-year-old man with dyslipidemia and low high‑density lipoprotein (<30 mg/dL) who was started on rosuvastatin 5 mg and now has nocturnal pruritus after three months, could the itching be caused by rosuvastatin and how should it be managed?
What are the 2026 guidelines for statin therapy initiation, intensity selection, LDL‑C targets, and monitoring in adult patients?
What is the definition of anemia?
How quickly should lithium dosage be titrated?
What is the recommended diagnostic workup and management for suspected Chiari I malformation?
Can an adult with diabetes use apple cider vinegar to lower post‑meal blood glucose, and what dosage and safety precautions are recommended?
What is the term for the horizontal line that appears above the upper lip when smiling, and can neuromodulators (e.g., onabotulinumtoxinA [Botox]) be used to treat it?
What chlorhexidine gluconate body wash regimen is recommended for MRSA decolonization, and what alternatives can be used if chlorhexidine is unavailable or contraindicated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.